Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner
(
) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.2%. By the end of trading, Alexion Pharmaceuticals rose $3.62 (3.9%) to $95.86 on average volume. Throughout the day, 2,068,528 shares of Alexion Pharmaceuticals exchanged hands as compared to its average daily volume of 1,546,400 shares. The stock ranged in a price between $93.34-$99.04 after having opened the day at $93.73 as compared to the previous trading day's close of $92.24. Other companies within the Health Care sector that increased today were:
(
), up 51.3%,
Bacterin International Holdings
(
), up 20.0%,
(
), up 19.3% and
(
), up 18.9%.
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-transforming therapeutic products. Alexion Pharmaceuticals has a market cap of $18.3 billion and is part of the drugs industry. The company has a P/E ratio of 64.2, above the S&P 500 P/E ratio of 17.7. Shares are down 1.6% year to date as of the close of trading on Friday. Currently there are 16 analysts that rate Alexion Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold.
TheStreet Ratings rates
Alexion Pharmaceuticals
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- You can view the full Alexion Pharmaceuticals Ratings Report.
On the negative front,
(
), down 61.1%,
(
), down 38.6%,
(
), down 18.7% and
(
), down 13.5% , were all laggards within the health care sector with
(
) being today's health care sector laggard.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
Health Care Select Sector SPDR
(
) while those bearish on the health care sector could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
null